Novartis AG (NOVN)
SIX
Closed
Aug 21, 2026
Day's Range
124.7052 wk Range
96.03Overview - NOVN - Novartis AG
Key Statistics
Valuation
Enterprise Value
226.91B
P/E (Trailing)
‪24.08‬
P/E (Forward)
‪16.23‬
PEG Ratio
‪-1.38‬
Price / Sales (TTM)
‪4.27‬
Price / Book
‪7.11‬
EV / EBITDA
‪12.29‬
Profitability
Gross Margin
‪75.18%‬
Profit Margin
‪22.50%‬
Operating Margin
‪34.62%‬
Return on Assets
‪10.25%‬
Return on Equity
‪30.35%‬
Ownership
Shares Outstanding
1.90B
Float
1.85B
Held by Insiders
‪2.11%‬
Held by Institutions
‪45.89%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪124.86‬
200-Day Avg
‪118.28‬
Dividends
Payout Ratio
‪69.86%‬
Frequency
Annual
Analyst Consensus
22 analysts
Average price target
‪CHF 125.16‬Market Cap - NOVN - Novartis AG
Peers - NOVN - Novartis AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on SIX.
Profile Summary - NOVN - Novartis AG
About
Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel, specializing in innovative medicines across multiple therapeutic areas including cardiovascular, immunology, neuroscience, oncology, and renal and metabolic diseases. The company operates through two primary divisions: Innovative…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
